In hemophiliac patients, which of the following should not be given?
**Core Concept**
The question is based on the management of hemophilia, a genetic disorder characterized by the deficiency of **clotting factors**, specifically **factor VIII** (Hemophilia A) or **factor IX** (Hemophilia B). Hemophiliac patients are at risk of bleeding due to their inability to form stable blood clots.
**Why the Correct Answer is Right**
Although the options are missing, typically, medications that should not be given to hemophiliac patients are those that increase the risk of bleeding, such as **aspirin** or other **antiplatelet agents** and **anticoagulants**. These medications can exacerbate the bleeding tendency by inhibiting **platelet aggregation** or interfering with the **coagulation cascade**.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation. However, if it were an option like **acetaminophen**, it would be incorrect because **acetaminophen** does not significantly affect platelet function or the coagulation pathway.
**Option B:** Similarly, without specifics, if this option were a **non-steroidal anti-inflammatory drug (NSAID)** without antiplatelet effects, it might be less harmful but still could pose some risk due to its effect on **renal function** and potentially **gastrointestinal mucosa**.
**Option C:** and **Option D:** would follow similar logic, focusing on the mechanism of action and potential to increase bleeding risk.
**Clinical Pearl / High-Yield Fact**
A crucial point in managing hemophiliac patients is avoiding medications that can worsen their bleeding tendency. **Aspirin**, due to its **antiplatelet effect**, is a classic example of a drug that should be used with caution or avoided in these patients.
**Correct Answer:** Correct Answer: D. Aspirin.